Nyrada Inc
ASX:NYR
Nyrada Inc
ASX:NYR
Price:
0.57
AUD
5.56%
Market Closed
Market Cap:
AU$139.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Nyrada Inc
ASX:NYR
|
AU |
|
IFAN Financial Inc
OTC:IFAN
|
US |
|
Matriks Bilgi Dagitim Hizmetleri AS
IST:MTRKS.E
|
TR |
|
Chongqing Sanxia Paints Co Ltd
SZSE:000565
|
CN |
|
Hangzhou Zhongya Machinery Co Ltd
SZSE:300512
|
CN |
|
Hargreaves Services PLC
LSE:HSP
|
UK |
|
G
|
Grown Rogue International Inc
CNSX:GRIN
|
CA |
|
B
|
Banco de Sabadell SA
XBER:BDSB
|
ES |
|
R
|
Revolution Beauty Group PLC
LSE:REVB
|
UK |
|
Net Insight AB
STO:NETI B
|
SE |
|
Fast Ejendom Danmark A/S
CSE:FED
|
DK |
|
Sinopec Engineering Group Co Ltd
HKEX:2386
|
CN |
|
C
|
Central Area Electrical Mechanical JSC
VN:CJC
|
VN |
|
K
|
Kepler Weber SA
BOVESPA:KEPL3
|
BR |
|
G
|
Guangdong Yangshan United Precision Manufacturing Co Ltd
SZSE:001268
|
CN |
|
Caribou Biosciences Inc
NASDAQ:CRBU
|
US |
Multiples-Based Value
The Multiples-Based Value of one
NYR
stock under the Base Case scenario is
hidden
AUD.
Compared to the current market price of 0.57 AUD,
Nyrada Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NYR Multiples-Based Value
LOCKED
Multiples Across Competitors
NYR Competitors Multiples
Nyrada Inc Competitors
Nyrada Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Nyrada Inc
ASX:NYR
|
131.4m AUD | 55 | -24.9 | -23.7 | -23.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD | 12.7 | 40.2 | 27.2 | 29 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.5 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD | 4.6 | 16.2 | 10 | 12.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF | 5.2 | 21.1 | 13 | 16.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.5B GBP | 5.1 | 29.1 | 16.1 | 22.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 9.8 | 7.3 | 8.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD | 2.4 | 16.7 | 7.1 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
